RCHA) Soars 66.67% After Study Drug RP-323 Reveals
Post# of 36
(Total Views: 873)
Posted On: 03/07/2018 8:41:36 AM
RCHA) Soars 66.67% After Study Drug RP-323 Reveals Potential Vital Role In Fighting Infections
March 6, 2018
Share
Rich Pharmaceuticals, Inc. (OTC Pink: RCHA) is a biotechnology company that focuses on the research, development, and commercialization of innovative therapies in oncology. Shares of the biotechnology company are surging 66.67%, through early trading on Tuesday, March 6, 2018. Over the past month, Rich Pharmaceuticals, Inc. has seen average daily volume of 52.1 million shares. However, volume of 279.82 million shares or dollar volume of $111,928, has already exchanged hands on the day.
Shares of Rich Pharmaceuticals, Inc. are jumping today, after the company announced that its study drug RP-323 shows signs of being a vital role in fighting infections on increasing white blood cells (WBC) in patients suffering from low WBC count.
http://emerginggrowth.com/rich-pharmaceutical...nfections/
March 6, 2018
Share
Rich Pharmaceuticals, Inc. (OTC Pink: RCHA) is a biotechnology company that focuses on the research, development, and commercialization of innovative therapies in oncology. Shares of the biotechnology company are surging 66.67%, through early trading on Tuesday, March 6, 2018. Over the past month, Rich Pharmaceuticals, Inc. has seen average daily volume of 52.1 million shares. However, volume of 279.82 million shares or dollar volume of $111,928, has already exchanged hands on the day.
Shares of Rich Pharmaceuticals, Inc. are jumping today, after the company announced that its study drug RP-323 shows signs of being a vital role in fighting infections on increasing white blood cells (WBC) in patients suffering from low WBC count.
http://emerginggrowth.com/rich-pharmaceutical...nfections/
(0)
(0)Rich Pharmaceuticals, Inc. (RCHA) Stock Research Links
Ignore bashers, get money.
Scroll down for more posts ▼